Form SCHEDULE 13G/A AN2 Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P. Feb 14, 2025 06:27PM
Form SC 13G/A AN2 Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P. Aug 13, 2024 05:40PM
Form SC 13G/A AN2 Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P. Feb 14, 2024 05:02PM
AN2 Therapeutics Announces Pricing of $70.0 Million Underwritten Offering of Common Stock Aug 15, 2023 10:42PM
Form SC 13G/A AN2 Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P. Feb 14, 2023 04:49PM


Apr 8, 2022 04:33PM Form SC 13G AN2 Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.